Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer
Condition(s):NeurotoxicityLast Updated:February 5, 2018Completed
Hide Studies Not Open or Pending
Condition(s):NeurotoxicityLast Updated:February 5, 2018Completed
Condition(s):NeurotoxicityLast Updated:July 17, 2015Unknown status
Condition(s):DLBCL; Neurotoxicity SyndromesLast Updated:December 9, 2021Terminated
Condition(s):Immune Effector Cell Associated Neurotoxicity SyndromeLast Updated:March 7, 2023Recruiting
Condition(s):NeurotoxicityLast Updated:September 19, 2017Completed
Condition(s):Gastrointestinal CancerLast Updated:August 9, 2022Recruiting
Condition(s):Peripheral NeuropathyLast Updated:July 28, 2020Unknown status
Condition(s):Lymphoma, B-Cell; NeurotoxicityLast Updated:May 11, 2023Recruiting
Condition(s):Vincristine Induced Neurotoxicity; Acute Lymphoblastic LeukaemiaLast Updated:July 8, 2020Completed
Condition(s):Non-small Cell Lung CancerLast Updated:June 1, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.